However, the major regulatory genes that cause changes in the above-mentioned metabolites and DCM phenotype may be IMPDH1, ENTPD2, AK7, AK2, and CANT1. These differential genes and metabolites are likely to serve as vital markers for diagnosis or treatment during heart failure progression in DCM. Here, AK7 is linked to familial dilated cardiomyopathy.